QuiVad

Home / Sweden / Ascelia Pharma AB

Ascelia Pharma AB

No short position is open on this share today.

Follow

Evolution of the disclosed total

0%0.2%0.4%0.6%0.8%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
The whole history, peaking at 1.44% on March 22, 2021. The shaded band is the year shown above.

March 18, 2021 today

Open positions

No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.

Follow by RSS

Get the moves on Ascelia Pharma AB by mail.

No account: one address, one link to confirm, one link to stop in every message.

History of disclosures

20 disclosures on record for this share.
DateFund% of capitalEnd of publication
August 19, 2026Citadel Securities (Europe) Limited0.65%
August 18, 2026Citadel Securities (Europe) Limited0.54%
July 23, 2026Citadel Securities (Europe) Limited0.73%
July 22, 2026Citadel Securities (Europe) Limited0.68%
July 16, 2026Citadel Securities (Europe) Limited0.73%
July 15, 2026Citadel Securities (Europe) Limited0.57%
July 13, 2026Citadel Securities (Europe) Limited0.79%
July 10, 2026Citadel Securities (Europe) Limited0.68%
July 6, 2026Citadel Securities (Europe) Limited0.79%
September 18, 2024Guevoura Fund0.80%
September 13, 2024Guevoura Fund0.78%
September 11, 2024Guevoura Fund0.60%
September 10, 2024Guevoura Fund1.36%
September 9, 2024Guevoura Fund0.92%
August 29, 2024Quartys Limited0.51%
March 23, 2021Catella Fondförvaltning AB0.62%March 23, 2021
March 23, 2021Celina Fondförvaltning AB0.62%
March 22, 2021Catella Fondförvaltning AB0.72%
March 22, 2021Celina Fondförvaltning AB0.72%
March 18, 2021Celina Fondförvaltning AB0.87%

Download 20 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in Sweden

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Ascelia Pharma AB, source Finansinspektionen, data as at August 19, 2026, https://www.quivad.com/action/ascelia-pharma-ab